Ultime notizie per Enbridge (OTC:ENBGF) Azioni

Enbridge owns extensive midstream assets that transport hydrocarbons across the us and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. The firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.

5.5 % Cum Red Pfd Registered Shs Series -A-

ENBRIDGE INC 5.50% PFD A by Enbridge Inc.

Enbridge Inc

RBC Capital analyst James McGarragle maintains Stella-Jones (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SJ#TSX">SJ</a>) with a Sector Perform and lowers the price target from C$97 to C$81.

News

Price Target

Analyst Ratings

TSX:SJ

RBC Capital Maintains Sector Perform on Stella-Jones, Lowers Price Target to C$81

WIIM

SRAD

Sportradar Group shares are trading higher after the company reported better-than-expected Q3 financial results. Needham reiterated a Buy rating on the stock.

In the current session, DLocal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLO#NASDAQ">DLO</a>) is trading at $8.61, after a 0.35% decrease. Over the past month, the stock fell by 7.12%, and in the past year, by 51.77%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1730996110_0.png" alt="Past Year Chart" />

<h3>DLocal P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 44.8 in the Financial Services industry, DLocal Inc. has a lower P/E ratio of 19.62. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730996110_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: DLocal

Roth MKM analyst Rohit Kulkarni maintains Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Neutral and raises the price target from $13 to $16.

LYFT

Roth MKM Maintains Neutral on Lyft, Raises Price Target to $16

UBS analyst Mark Carden maintains Performance Food Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFGC#NYSE">PFGC</a>) with a Buy and raises the price target from $98 to $102.

PFGC

UBS Maintains Buy on Performance Food Gr, Raises Price Target to $102

Waystar Holding shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 guidance above estimates.

LSPD

Lightspeed Commerce shares are trading higher after the company reported better-than-expected Q2 financial results.

Roth MKM analyst Eric Handler maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $180 to $182.

TTWO

Roth MKM Maintains Buy on Take-Two Interactive, Raises Price Target to $182

UBS analyst John Lovallo maintains Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) with a Buy and raises the price target from $197 to $218.

UBS Maintains Buy on Owens-Corning, Raises Price Target to $218

PENN Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) reported third-quarter financial results before the market opened on Thursday. Here&#8217;s<a href="https://www.benzinga.com/quote/PENN/earnings"> what you need to know.</a>
What To Know: PENN reported an adjusted loss of 25 cents per share, missing estimates for a loss of 24 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Revenue for the quarter came in at $1.64 billion, slightly below expectations of $1.66 billion, but up 1.24% from $1.62 billion in the same period last year.
As of Sept. 30, PENN had total liquidity of $1.8 billion, including $834 million in cash. The company said it has been investing in both physical and digital upgrades, especially through its ESPN BET platform, which expanded to 19 U.S. states this quarter after launching in New York in September.
PENN also said its accelerating hotel room renovations at L&#8217;Auberge Casino Lake Charles, with the upgrades expected to wrap up by January 2025. According to CEO Jay Snowden, these moves are part of PENN's broader strategy to improve customer retention and revenue per customer.
&#8220;Stable consumer demand in our retail business was offset by unfavorable hold in our Northeast segment and volume declines in our South segment associated with severe weather disruptions and accelerated hotel remodeling. The fourth quarter is off to a stronger start, led by several markets including Michigan, Ohio, and St. Louis,&#8221; Snowden said.
Outlook: PENN remains focused on expanding its Interactive offerings, with plans to launch an iCasino app in Pennsylvania in early 2025, pending regulatory approval. The company said its development projects are on schedule, with Hollywood Joliet expected to open ahead of plan in the latter half of 2025.
PENN Price Action: Penn Entertainment shares were up 4.04% at $20.02 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="551" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07095523/PENN-1024x551.png" alt="" class="wp-image-635481" style="width:475px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07095523/PENN-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07095523/PENN-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07095523/PENN-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07095523/PENN.png 1138w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41810110/duke-energy-q3-eps-falls-short-on-higher-costs-and-storm-impacts-reaffirms-fy24-outlook">Duke Energy Q3 EPS Falls Short On Higher Costs And Storm Impacts, Reaffirms FY24 Outlook</a></li>
</ul>
Photo via Shutterstock..

Movers

PENN

PENN Entertainment Stock Climbs Despite Q3 Earnings Miss: What's Going On?

LFST

LifeStance Health shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.

RBC Capital analyst Drew McReynolds maintains Stingray Group Inc (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RAY#TSX">RAY</a>) with a Outperform and raises the price target from C$10 to C$11.

TSX:RAY

TSX:RAY.A

RBC Capital Maintains Outperform on Stingray Group Inc, Raises Price Target to C$11

GDRX

GoodRx Holdings shares are trading lower after the company reported worse-than-expected Q3 financial results and issued Q4 and FY24 sales guidance below estimates.

UBS analyst Robin Farley maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Neutral and raises the price target from $19 to $29.

NCLH

UBS Maintains Neutral on Norwegian Cruise Line, Raises Price Target to $29

Halliburton Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) shares are trading lower after the company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41801890/halliburton-announces-third-quarter-2024-results" rel="noreferrer noopener">third-quarter results below the street expectations.</a>
HAL reported a third-quarter revenue decline of 1.8% year-over-year to $5.697 billion, missing the consensus of $5.828 billion.
Completion and Production revenue was $3.299 billion, down 5% YoY, and the operating income declined to $669 million, reflecting reduced U.S. pressure pumping and lower tool sales in North America and Europe, partially offset by gains in the Middle East.
Drilling and Evaluation revenue rose 3.5% YoY to $2.398 billion, with operating income at $406 million, supported by higher Latin American drilling, global software sales, and increased Middle East wireline activity, offset by declines in Europe, North America, and Latin America testing.
HAL&#8217;s North America revenue declined 8.5% YoY to $2.386 billion, impacted by reduced U.S. pressure pumping and Gulf hurricane disruptions, partially offset by higher U.S. artificial lift and Canadian/Gulf stimulation activity. International revenue was $3.3 billion, flat sequentially.
Operating income stood at $871 million (-16% YoY), with an operating margin of about 15.3%, down 258 bps YoY. Adjusted operating margin was 17.3%, down 54 bps.
Adjusted EPS was $0.73, down from $0.79 a year ago and <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">below the consensus of $0.75.</a>
The company repurchased ~$200 million of its common stock during the quarter. Operating cash flow was $2.41 billion for the nine months ended September, and free cash flow was $1.542 billion. For the quarter, operating cash flow was $841 million, and FCF was $543 million.
&#8220;We experienced a $0.02 per share impact to our adjusted earnings from lost or delayed revenue due to the August cybersecurity event and storms in the Gulf of Mexico. Our full year expectations for free cash flow and cash return to shareholders remain unchanged, and we <a href="https://www.benzinga.com/calendars/guidance">expect both to accelerate in the fourth quarter</a>,&#8221; commented Jeff Miller, Chairman, President and CEO.
&#8220;I see solid opportunities across business lines and geographies for Halliburton. As we execute on our strategy, we will target opportunities to deliver unique value, allocate capital to the highest return opportunities, and prioritize free cash flow generation and shareholder returns,&#8221; added Miller.
Price Action: HAL shares are down 4.44% at $29.15 at the last check Thursday.

Earnings

Equities

Halliburton Misses Q3 Expectations As North America Sales Falter; International Growth On The Horizon

Roth MKM analyst Craig Irwin maintains Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) with a Buy and lowers the price target from $25 to $20.

WOLF

Roth MKM Maintains Buy on Wolfspeed, Lowers Price Target to $20

In an unexpected turn, some elite golfers are trading traditional pharmaceuticals for <a href="https://www.benzinga.com/markets/psychedelics">psychedelics</a> like psilocybin and ayahuasca, hoping to gain a mental edge. As Double Blind <a href="https://doubleblindmag.com/pro-golfers-mushrooms-ayahuasca/">reported</a>, while both compounds are associated with altered states, they're increasingly being used in microdoses by golfers seeking to <a href="https://www.benzinga.com/markets/cannabis/24/10/41551319/beyond-the-brain-heart-activity-may-shape-psychedelic-experiences-study-finds">improve focus and reduce performance anxiety</a>. Although the practice remains niche, a growing number of professional players are embracing these substances to elevate their game.
<h3 class="wp-block-heading">Microdosing On The Course: Psilocybin For Focus And Calm</h3>
One top <a href="https://www.benzinga.com/topic/pga-tour">PGA Tour</a> player who wished to remain anonymous recently <a href="https://www.golfdigest.com/story/why-serious-players-are-doing-psychedelics-like-mushrooms-and-ayahuasca?utm_medium=social&amp;utm_source=instagram&amp;utm_campaign=golfdigest">shared</a> his experience with Golf Digest. "<a href="https://www.benzinga.com/topic/psilocybin">Psilocybin</a> allows me to get a deep breath on the course that I haven't been able to get in years," he said. Since microdosing, he said he's seen measurable performance gains, noting it helps him assess each shot without judgment or fear.
<h3 class="wp-block-heading">DJ Trahan's Transformation Through Plant Medicine</h3>
DJ Trahan, a two-time PGA Tour winner, turned to psychedelics after struggling with his game. His friend Taylor Massey, a former amateur champion who now works as a "psychedelic advisor" for golfers, introduced Trahan to <a href="https://www.benzinga.com/topic/ayahuasca">ayahuasca</a> in 2019. Reflecting on his transformative experience, Trahan explained, "My golf had been struggling, and I felt completely lost. I never understood that the answers were within me. Plant medicine gets an unfortunate reputation because people look at it as drugs. They're not honoring it for what it is."
Massey, who helps golfers incorporate psychedelics into their routines, views plant medicine as a natural stress remedy, free from pharmaceuticals. "This is just a natural remedy in tiny doses," he told Golf Digest. Unlike drugs like Zoloft or Wellbutrin, Massey noted, psychedelics offer an alternative stress-management approach, which is gaining popularity among those open to new therapies.
<h3 class="wp-block-heading">Juniper Reserve Researches Psychedelics And Golf Performance</h3>
The trend has caught researchers&#8217; attention. Juniper Reserve in Oregon is collaborating with psychedelics expert Dr. Robin Carhart-Harris to study psilocybin&#8217;s impact on golf performance. In the study, golfers take a microdose before teeing off, with a one-hour wait for effects to kick in.
According to Melissa Sanchez, Juniper Reserve's wellness director, the aim is to help golfers "make small modifications within their own practices" that could lead to lasting improvements. Sanchez sees the study as a way to address the mental barriers that players develop over years of repetitive practice. "This is as cutting-edge as health and wellness can be," she said. "In golf, there's this idea that once you've been playing for long enough, you develop specific habits that are hard to break out of."
<h3 class="wp-block-heading">The Shifting Culture Around Psychedelics In Golf</h3>
Though psilocybin and <a href="https://www.benzinga.com/topic/dmt">DMT</a> are not banned by golf&#8217;s anti-doping rules, psychedelic use in sports remains unconventional. However, with growing interest in their therapeutic benefits, psychedelics are slowly gaining traction in high-stakes environments like golf, where focus is key.
The trend signals a shift in the culture of sports wellness. While pharmaceuticals have long dominated mental health in sports, some players are now turning to psychedelics to boost focus, manage stress and enhance performance.
Cover image made with AI

Cannabis

Psychedelics

Sports

Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief

UBS analyst Alex Kramm maintains MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Buy and raises the price target from $330 to $335.

MKTX

UBS Maintains Buy on MarketAxess Holdings, Raises Price Target to $335

Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is set to give its latest quarterly earnings report on Friday, 2024-11-08. Here's what investors need to know before the announcement.
Analysts estimate that Fulgent Genetics will report an earnings per share (EPS) of $-0.15. 
The market awaits Fulgent Genetics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.45, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Fulgent Genetics's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.30</td>
<td>-0.32</td>
<td>-0.29</td>
<td>-0.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.15</td>
<td>-0.01</td>
<td>0.28</td>
<td>-0.39</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
<td>13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730995867_0.png" alt="eps graph" />
<h3>Tracking Fulgent Genetics's Stock Performance</h3>
Shares of Fulgent Genetics were trading at $22.68 as of November 06. Over the last 52-week period, shares are down 14.28%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/FLGT/earnings">To track all earnings releases for Fulgent Genetics visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Enbridge

Notizie

Ultime notizie per Enbridge (OTC:ENBGF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO